-
公开(公告)号:DK0649654T3
公开(公告)日:1999-09-20
申请号:DK94117179
申请日:1991-11-21
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:ES2129563T3
公开(公告)日:1999-06-16
申请号:ES94117179
申请日:1991-11-21
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJORG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:CZ280148B6
公开(公告)日:1995-11-15
申请号:CS89288
申请日:1988-02-12
Applicant: HOECHST AG
Inventor: URBACH HANSJORG DR , HENNING RAINER DR , SCHOLKENS BERNWARD DR , BECKER REINHARD DR
IPC: C07D223/32 , A61K31/395 , A61K31/445 , A61K31/55 , A61K38/00 , A61P9/00 , A61P9/12 , A61P27/02 , A61P27/06 , A61P43/00 , C07D225/04 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07K5/02 , C07K5/06
Abstract: Cyclopenta-azocine and -azepine derivs. of formula (I) and their salts are new. In (I) m = 1 or 2; n = 0-2; R1 and R2 = H; 1-6C alkyl (opt. substd. once by OH, SH, 1-2C alkoxy, 1-2C alkylthio, COOH, 1-2C alkoxycarbonyl, 3-indolyl, imidazolyl, CONH2, amino or guanidino); 2-6C alkenyl; 3-9C cycloalkyl or cycloalkenyl; 3-7C cycloalkyl (1-4C) alkyl; 6-12C aryl (opt. partially hydrogenated) or 6-12C aryl (1-4C) alkyl (opt. OH substd. in aryl); R3 and R4 = H, 1-6C alkyl, 2-6C alkenyl or 6-12C aryl (1-4C) alkyl, opt. substd. in aryl by one MeO or NO2; Y = H or OH; Z = H; or Y and Z are together oxo; X = 1-6C alkyl (opt. substd. by NH2, acylamino, 1-6C alkylamino and/or di(1-4C)alkylamino); 2-6C alkenyl; 5-9C cycloalkyl, 1-R1-piperidin-4-yl, 6-12C aryl (opt. substd. by 1-3 of 1-4C alkyl or alkoxy, OH, halo, NO2, NH2 (itself opt. substd. by 1 or 2 1-4C alkyl) and/or methylenedioxy) or 3-indolyl; any free OH, SH, COOH, amino or guanidino can be protected conventionally.
-
公开(公告)号:DE59106422D1
公开(公告)日:1995-10-12
申请号:DE59106422
申请日:1991-11-21
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , TEETZ VOLKER DR , URBACH HANSJOERG DR
IPC: A61K38/55 , A61K31/275 , A61K31/277 , A61K31/40 , A61K31/401 , A61K31/41 , A61K31/425 , A61K31/455 , A61K31/47 , A61K31/55 , A61K45/06 , A61P3/00 , A61P3/14 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00
Abstract: An angiotensin converting enzyme inhibitor (I) can be used in combination with Ca antagonists (III) in the prevention and therapy of proteinuria. Pref. (A) Ramipril and felodipine; (B) Ramipril and 4-(2,3-dichlorophenyl) -2,6-dimethyl-3- (1,2,4-oxadiazol-5-yl) -S-isopropoxy carbonyl-1,4-dihydropyridine (IIb), (c) Trandolapril and felodipine; (D) Trandolapril and (IIb), (E) Trandolapril and Verapamil; (F) Quinapril and felodipine; (G) Quinapril and (IIIb) or the physiologically acceptable salts of these components.
-
公开(公告)号:BR9300761A
公开(公告)日:1993-09-14
申请号:BR9300761
申请日:1993-03-05
Applicant: HOECHST AG
Inventor: HEITSCH HOLGER DR , HENNING RAINER DR , WAGNER ADALBERT DR , GERHARDS HERMANN DR , BECKER REINHARD DR , SCHOELKENS BERNWARD DR
IPC: A61K31/415 , A61K31/4164 , A61K31/64 , A61P9/10 , A61P9/12 , C07D233/84 , C07D233/86 , C07D233/90
Abstract: Compounds of the formula (I) in which R is, for example, ethyl, R is, for example, methyl, n is, for example, zero, R is, for example, COOH and R is, for example, SO2NHCONHCH3 are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:CS1092A3
公开(公告)日:1992-07-15
申请号:CS1092
申请日:1992-01-03
Applicant: HOECHST AG
Inventor: WAGNER ADALBERT DR , ENGLERT HEINRICH DR , KLEEMANN HEINZ-WERNER DR , GERHARDS HERMANN DR , SCHOLKENS BERNWARD PROF DR , BECKER REINHARD DR , LINZ WOLFGANG DR
IPC: A61K31/40 , A61K31/415 , A61K31/425 , A61K31/435 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/445 , A61K31/505 , A61K31/535 , A61K31/54 , A61K31/64 , A61P9/00 , A61P9/08 , A61P9/10 , A61P9/12 , A61P13/02 , A61P15/00 , A61P43/00 , C07D207/34 , C07D207/36 , C07D233/54 , C07D233/66 , C07D233/68 , C07D233/70 , C07D233/84 , C07D233/90 , C07D249/02 , C07D255/02 , C07D257/02 , C07D257/04 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D417/12 , C07D453/02 , C07D521/00 , C07D231/10 , C07D207/30 , C07D249/04 , C07D249/08 , A61K31/41
Abstract: Azole derivative of the general formula (I) in which A, L, O, R , X, Y, Z and q have the meanings given, a process for their preparation, pharmaceutical preparations and the use of the compounds are described. Azole derivatives of the formula I where the symbols have, for example, the following meanings: R = (C2-C10)-alkyl Z = nitrogen X and Y = independently of one another CR L = -CH2- q = zero or 1 A = biphenyl radical which is substituted, for example, by R R = halogen or hydrogen R = SO2-NH-CO-OR and R = phenyl, are highly active antagonists of angiotensin II receptors.
-
公开(公告)号:DE3684636D1
公开(公告)日:1992-05-07
申请号:DE3684636
申请日:1986-05-14
Applicant: HOECHST AG
Inventor: URBACH HANSJOERG DR , HENNING RAINER DR , BECKER REINHARD DR
IPC: C07D521/00 , A61K38/00 , A61K38/55 , A61P9/12 , A61P43/00 , C07D209/52 , C07K1/02 , C07K1/06 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/062 , C07K5/068 , C07K14/81 , A61K37/02
Abstract: Bicyclic amino acid peptide derivs. of formula (I) and their physiologically innocuous salts are new. n is 0, 1 or 2; R is H, 1-6C alkyl or 7-9C aralkyl; R1 is H, 1-6C alkyl opt. substd. by amino, 1-4C acylamino or benzamido, 2-6C alkenyl, 5-9C cycloalkyl, 5-9C cycloalkenyl, (5-7C cycloalkyl)-(1-4C alkyl), aryl or partially hydrogenated aryl opt. substd. by 1-4C alkyl, 1-2C alkoxy or halogen, aryl-(1-4C alkyl) or aroyl-(1C alkyl) opt. substd. in the aryl residue by 1-4C alkyl, 1-2C alkoxy or halogen, a mono- or bicyclic heterocyclic residue with 5-7 or 8-10 ring atoms of which 1-2 are S or O and/or of which 1-4 are N, or a side-chain of a naturally occurring amino acid; R2 is H, 1-6C alkyl, 2-6C alkenyl or aryl-(1-4C alkyl); x is 1-6C alkyl, 2-6C alkenyl, 5-9C cycloalkyl, aryl opt. mono-, di- or trisubstd. by 1-4C alkyl, 1-4C alkoxy, OH, halogen, NO2, NH2, 1-4C alkylamino or di-(1-4C alkyl) amino (excluding OH, NH2 or mono-alkylamino adjacent to an olefinic C-C double bond) or 3-indolyl.
-
公开(公告)号:DE3482385D1
公开(公告)日:1990-07-05
申请号:DE3482385
申请日:1984-06-30
Applicant: HOECHST AG
Inventor: URBACH HANSJOERG DR , HENNING RAINER DR , BECKER REINHARD DR
IPC: A61K31/40 , A61K31/403 , A61K31/405 , A61K38/00 , A61K38/55 , A61P9/12 , A61P43/00 , C07D209/52 , C07D221/04 , C07K1/113 , C07K5/02 , C07K5/06 , C07K5/08 , C07K14/81
Abstract: The invention relates to compounds of the formula I (I) in which n denotes 0 or 1, R denotes hydrogen, alkyl, alkenyl or aralkyl, R1 denotes hydrogen or alkyl, which can optionally be substituted by amino, acylamino or benzoylamino, alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, aryl or partially hydrogenated aryl, each of which can be substituted by alkyl, alkoxy or halogen, aralkyl or aroylalkyl, both of which can be substituted in the aryl radical as defined previously, a monocyclic or bicyclic S- or O- and/or N-heterocyclic radical or a side chain of an aminoacid, R2 denotes hydrogen, alkyl, alkenyl or aralkyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen, or Y and Z together denote oxygen, X denotes alkyl, alkenyl, cycloalkyl, aryl, which can be monosubstituted, disubstituted or trisubstituted by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, acylamino, alkylamino, dialkylamino and/or methylenedioxy, or 3-indolyl, and to a process for their preparation, agents containing them and and their use, and to 2-azabicyclo[3.1.0]hexane derivatives as intermediates, and a process for their preparation.
-
公开(公告)号:DE3818245A1
公开(公告)日:1989-12-07
申请号:DE3818245
申请日:1988-05-28
Applicant: HOECHST AG
Inventor: BECKER REINHARD DR , HENNING RAINER DR , URBACH HANSJOERG DR , TEETZ VOLER DR , ENGLERT HEINRICH CHRIST DR , MANIA DIETER DR
Abstract: The invention relates to combinations of angiotensin converting enzyme inhibitors with potassium channel modulators, process for the preparation thereof and their use as medicines.
-
公开(公告)号:DE3704661A1
公开(公告)日:1988-08-25
申请号:DE3704661
申请日:1987-02-14
Applicant: HOECHST AG
Inventor: URBACH HANSJOERG DR , HENNING RAINER DR , SCHOELKENS BERNWARD DR , BECKER REINHARD DR
IPC: C07D223/32 , A61K31/395 , A61K31/445 , A61K31/55 , A61K38/00 , A61P9/00 , A61P9/12 , A61P27/02 , A61P27/06 , A61P43/00 , C07D225/04 , C07D401/12 , C07D403/06 , C07D403/12 , C07D405/12 , C07K5/02 , C07K5/06
Abstract: Cyclopenta-azocine and -azepine derivs. of formula (I) and their salts are new. In (I) m = 1 or 2; n = 0-2; R1 and R2 = H; 1-6C alkyl (opt. substd. once by OH, SH, 1-2C alkoxy, 1-2C alkylthio, COOH, 1-2C alkoxycarbonyl, 3-indolyl, imidazolyl, CONH2, amino or guanidino); 2-6C alkenyl; 3-9C cycloalkyl or cycloalkenyl; 3-7C cycloalkyl (1-4C) alkyl; 6-12C aryl (opt. partially hydrogenated) or 6-12C aryl (1-4C) alkyl (opt. OH substd. in aryl); R3 and R4 = H, 1-6C alkyl, 2-6C alkenyl or 6-12C aryl (1-4C) alkyl, opt. substd. in aryl by one MeO or NO2; Y = H or OH; Z = H; or Y and Z are together oxo; X = 1-6C alkyl (opt. substd. by NH2, acylamino, 1-6C alkylamino and/or di(1-4C)alkylamino); 2-6C alkenyl; 5-9C cycloalkyl, 1-R1-piperidin-4-yl, 6-12C aryl (opt. substd. by 1-3 of 1-4C alkyl or alkoxy, OH, halo, NO2, NH2 (itself opt. substd. by 1 or 2 1-4C alkyl) and/or methylenedioxy) or 3-indolyl; any free OH, SH, COOH, amino or guanidino can be protected conventionally.
-
-
-
-
-
-
-
-
-